
Pharmacon Remedies And Research Private Limited
Manufactures medicines for healthcare industry.
Manufactures medicines for healthcare industry.
Pharmacon Remedies And Research Private Limited (PRARPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 October 2013 and has a history of 11 years and four months. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.13 M.
The company currently has active open charges totaling ₹6.07 M.
Jayaraj Veetil, Joemon Thaliyath, Suresh Cherakkatil, and Two other members serve as directors at the Company.
Thrissur, Kerala, India
+91-XXXXXXXXXX
-
U24230KL2013PTC035323
035323
Private Limited Indian Non-Government Company
31 Oct 2013
30 Sep 2023
31 Mar 2023
Unlisted
Roc Ernakulam
Pharmacon Remedies And Research Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Herbal Oil, Pain Balm & Ointments, Common Disease Medicines, Cough Syrup, Hand Sanitizers & Personal Hygiene, Hand Sanitizer & Disinfectant.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jayaraj Veetil ![]() | Managing Director | 31-Oct-2013 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Joemon Thaliyath ![]() | Additional Director | 25-Jul-2024 | Current |
Suresh Cherakkatil ![]() | Director | 21-Dec-2023 | Current |
Krishnankutty Nair ![]() | Director | 15-Jun-2016 | Current |
Sureshkumar Chonatt ![]() | Director | 11-Apr-2016 | Current |
Pharmacon Remedies And Research Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 8.31% decrease. The company also saw a substantial fall in profitability, with a 31.03% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.11%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2019, Pharmacon Remedies And Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Joemon Thaliyath is a mutual person
Suresh Cherakkatil is a mutual person
₹6.07 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
03 Mar 2022 | Canara Bank | ₹0.37 M | Open |
19 Aug 2020 | Canara Bank | ₹0.70 M | Open |
13 Feb 2014 | Canara Bank | ₹3.00 M | Open |
13 Feb 2014 | Canara Bank | ₹2.00 M | Open |
Unlock and access historical data on people associated with Pharmacon Remedies And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pharmacon Remedies And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacon Remedies And Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Joemon Thaliyath was appointed as a Additional Director was appointed as a Additional Director on 25 Jul 2024 & has been associated with this company since 7 months 9 days .
Suresh Cherakkatil was appointed as a Director was appointed as a Director on 21 Dec 2023 & has been associated with this company since 1 year 2 months .
Pharmacon Remedies And Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Pharmacon Remedies And Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ernakulam.
A charge with Canara Bank amounted to Rs. 0.37 M with Charge ID 100542052 was registered on 03 Mar 2022.
A charge with Canara Bank amounted to Rs. 0.70 M with Charge ID 100361294 was registered on 19 Aug 2020.
Pharmacon Remedies And Research Private Limited was incorporated on 31 Oct 2013.
The authorized share capital of Pharmacon Remedies And Research Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.13 M.
Currently 5 directors are associated with Pharmacon Remedies And Research Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Pharmacon Remedies And Research Private Limited is Building No. 11/76 ( New 11/418) Kaniyarkode Village, Pan Chayath India, Thiruvillwamala, Kerala, 680594.
The corporate identification number (CIN) of Pharmacon Remedies And Research Private Limited is U24230KL2013PTC035323 and the company number is 035323 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2020, the revenue trend for Pharmacon Remedies And Research Private Limited has fallen by -8.31%.
The financial reports for the fiscal year 2020 indicates that The net worth of Pharmacon Remedies And Research Private Limited has experienced an downturn of -20.11%.
As per the financial statements for fiscal Year 2020, The total open charges for Pharmacon Remedies And Research Private Limited amount to ₹ 6.07 M.
The most recent Balance Sheet for Pharmacon Remedies And Research Private Limited was filed with the ROC on 31 Mar 2023.
AN
PM
SC
JR
SS
JV